Dr. E. Cartier Esham

Senior Director, Emerging Companies Health and Regulatory Affairs
Biotechnology Industry Organization


Dr. Cartier Esham is currently the Senior Director of Emerging Companies Health and Regulatory Affairs for the Biotechnology Industry Organization (BIO).  She is responsible for working on health and regulatory issues important to BIO's small biotechnology companies, the majority of which do not yet have a product in the market place. Issues of particular importance to emerging companies include intellectual property, technology transfer, clinical trials, investor relations, and funding. The emerging companies section also works on a wide range of FDA regulatory issues and is a strong advocate for NIH's biomedical research programs.

Prior to joining BIO, Esham was a Vice President and Director of Research at Dutko Worldwide, a private consulting firm in Washington, D.C.  There she worked on a variety of environmental, education, science, technology and health care related issues both on the federal and state/local levels.

Esham has a Ph.D. in Microbiology from the University of Georgia, a Master's degree in Marine Biology from the University of North Carolina at Wilmington and a Bachelor of Science Degree from the University of Kentucky. She has published papers in peer-reviewed science journals on water quality, marine microbial ecology and bacterial cloning.  Dr. Esham has served on the Brain Trust for the Global Innovation Forum, a project of the National Foreign Trade Council to create a greater understanding of the innovation ecosystem to enable effective solutions to global challenges.